| ORIGINAL ARTICLE |
|
| Year : 2006 | Volume
: 54
| Issue : 4 | Page : 261-265 |
|
|
Inter-instrument agreement and influence of central corneal thickness on measurements with Goldmann, pneumotonometer and noncontact tonometer in glaucomatous eyes
Viney Gupta, Parul Sony, Harish C Agarwal, Ramanjit Sihota, Ajay Sharma
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi - 110 029, India
Correspondence Address:
Viney Gupta
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi - 110 029
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0301-4738.27952
|
|
|
Purpose: This study was conducted to compare the intraocular pressure (IOP) measurements by the Goldman applanation tonometer (GAT), non contact tonometer (NCT) and the ocular blood flow (OBF) pneumotonometer in different IOP ranges in glaucomatous eyes. The effect of central corneal thickness (CCT) on IOP measurement in chronic glaucomatous eyes using the three different tonometers was also evaluated.
Materials and Methods: IOP measurements of 130 eyes of primary glaucoma patients were performed using GAT by an ophthalmologist while NCT and OBF-pneumotonometer measurements were performed by an experienced optometrist. The IOP values were compared amongst the three instruments in the three different IOP ranges (0-18 mmHg, >18 to 25 mmHg, > 25 mmHg). CCT was also measured in all patients.
Results: The mean of paired difference between GAT and NCT was 0.9 ± 3.1 mmHg while that between GAT and OBF-pneumotonometer was 0.3 ± 3.4 mmHg. The OBF-pneumotonometer and NCT were more affected by corneal thickness (0.41 mmHg and 0.4 mmHg / 10 µ corneal thickness respectively) while GAT was the least affected by corneal thickness (0.3 mmHg / 10 µ corneal thickness) though the difference was not statistically significant ( P =0.42).
Conclusion: With appropriate correction for corneal thickness the NCT and OBF-pneumotonometer can be used as reliably as GAT in following up glaucomatous patients.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
